RBP4 and metabolic dysfunction-associated steatotic liver disease: This gene’s product interacts with ACACA. It has an impact in FAM by receptor interaction and changes in RBP4 gene, which plays a role in non-alcoholic fatty liver disease and can contribute to insulin resistance51.